RVTY:NYSE
Revvity Inc
US$85.45
arrow_downward
-1.56%(-1.35) 1 天
4月28日, GMT-4 15:49:00 · USD
search
所有股票代码
1 天
5 天
1 个月
6 个月
年初至今
1 年
5 年
最大
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 RVTY 生成关键数据洞见…
开盘价
US$86.94
最高价
US$87.24
最低价
US$84.69
市值
九七.〇五亿
平均成交量
九六.二八万
成交量
七〇.〇〇万
52 周最高价
US$118.30
52 周最低价
US$81.36
Beta 版
一.一三
流通股数
一.一二亿
员工人数
一万
新闻报道
来自全网
MarketBeat
·
9分钟前
FormFactor (NASDAQ:FORM) Shares Gap Down - Time to Sell?
ChartMill
·
49分钟前
Here are the top movers in Tuesday's session.
Tiger Brokers
·
53分钟前
尾盘：美股走低科技股领跌 纳指下跌0.9%
资料
Revvity, Inc. is an American company in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, especially in relation to approaches making use of new cell therapy or gene therapy developments. Its origins lie with the long-existing company PerkinElmer, which has been in a variety of business lines.
In 2022, a split of PerkinElmer resulted in one part, comprising its applied, food and enterprise services businesses, being sold to the private equity firm New Mountain Capital for $2.45 billion and thus no longer being public but keeping the PerkinElmer name. The other part, comprising the life sciences and diagnostics businesses, remained public but required a new name, which in 2023 was announced as Revvity, Inc. From the perspective of Revvity, the goal of creating a separate company was that its businesses might show greater profit margins and more in the way of growth potential. An associated goal was to have more financial flexibility moving forward. On May 16, 2023, the PerkinElmer stock symbol PKI was replaced by the new symbol RVTY. Wikipedia
Revvity Inc简介